艾滋病疫苗在幾個月後停止工作 震驚研究人員

艾滋病疫苗在幾個月後停止工作 被震驚的研究人員發現
AIDS vaccines stop working after a few months, shocked researchers discover
Saturday, April 03, 2010
by: Ethan A. Huff, staff writer

(NaturalNews) An experimental new AIDS vaccine is proving to be effective for only a very short time, according to researchers who have been finding it difficult to explain whether or not the drug is actually useful. Dr. Nelson Michael, a colonel at the Walter Reed Army Research Institute of Research in Maryland, and his team observed only a minor, temporal benefit in patients who took the vaccine, followed by a decline in efficacy.
（NaturalNews）一種試驗性的新艾滋病疫苗，被證明是有效只得一很短的時間，根據研究人員他們已發覺難以解釋，藥物是否真的有用。一名在馬里蘭州沃爾特里德陸軍研究所的研究的上校邁克爾納爾遜博士，和他的隊伍觀察到，對打疫苗的患者只有輕微、短暫的利益，跟隨着衰退的療效。
The experimental vaccine is a combination of Sanofi-Pasteur's ALVAC canarypox/HIV vaccine and VaxGen's AIDSVAX. After AIDSVAX was found to be ineffective in 2003, researchers decided to combine it with ALVAC to see if that combination would work. Early results appeared to show that the vaccine reduced the risk of becoming infected with AIDS by 31 percent. However within a year, the risk level seemed to return back to normal.
實驗疫苗是一種賽諾菲巴斯德公司開發的ALVAC金絲雀痘/艾滋病毒疫苗和瓦克斯根的AIDSVAX的組合。 在AIDSVAX於 2003年被發現無後效，研究人員決定將它與ALVAC結合，去看結合是否掂。早期的結果似乎表明，疫苗降低成為感染艾滋病的風險約30%。但在一年之內，風險程度似乎返回到正常。
At the Conference on Retroviruses and Opportunistic Infections in San Francisco, the team explained that they may be able to come up with a new trial to verify the legitimacy of the vaccine. Dr. Michael said he plans to work with Dr. Anthony Fauci from the U.S. National Institute of Allergy and Infectious Diseases to develop new trials to be conducted in Asia or Africa.
在三藩市的逆轉病毒和機會性感染的會議上，隊伍解釋他們可能能夠想出一個新的試驗，去驗證疫苗的合法性。邁克爾博士說，他打算與美國國立過敏和傳染病研究所的安東尼福西博士，發展在亞洲或非洲進行的新試驗。
It is important to note that studies conducted on vitamins and nutrients showing positive results are usually accompanied with disclaimers by researchers that further study is needed to verify the results. In this case, researchers have been working overtime to defend the legitimacy of the experimental AIDS vaccine trial, despite the fact that they admit the results are questionable and they cannot determine whether it was actually a success.
The team plans to follow up the study by evaluating blood samples from vaccinated participants to measure their antibody levels. They hope to find evidence that the vaccine is exerting some kind of influence on participants' immune systems.

Previous AIDS vaccines have all proven to be a failure. In 2008, two of the most viable options gathered from a 20-year search not only failed to provide protection from the disease but actually increased one's risk of becoming infected with AIDS.

Since its first discovery in the 1980s, it is estimated that roughly 25 million people have died from AIDS. Various combinations of pharmaceutical drugs are offered to AIDS patients to help control the disease, but according to mainstream experts, there is no cure for it.
http://www.naturalnews.com/028507_AIDS_vaccines.html